nygazet.com logo
UniQure Stock Launches More Than 240% After Successfully Treating Huntington's Disease
health

UniQure Stock Launches More Than 240% After Successfully Treating Huntington's Disease

1 min read

UniQure stock catapulted Wednesday after the company said its experimental gene therapy successfully treated Huntington's disease.

UniQure (QURE) stock catapulted more than 200% Wednesday after the company said its experimental gene therapy successfully treated Huntington's disease. Huntington's disease is a neurological condition that slowly destroys brain cells, robbing patien... [2474 chars]

Read Original Article

Source: Investor's Business Daily

Visit Source

Share this article